IBLLX
Price
$36.09
Change
+$0.11 (+0.31%)
Updated
Oct 17 closing price
Net Assets
1.5B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

IBLLX vs RLBCX

Header iconIBLLX vs RLBCX Comparison
Open Charts IBLLX vs RLBCXBanner chart's image
Transamerica Multi-Managed Balanced C
Price$36.09
Change+$0.11 (+0.31%)
VolumeN/A
Net Assets1.5B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
IBLLX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
IBLLX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBLLX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. IBLLX (1.5B). RLBCX pays higher dividends than IBLLX: RLBCX (1.49) vs IBLLX (0.73). IBLLX was incepted earlier than RLBCX: IBLLX (23 years) vs RLBCX (23 years). IBLLX (1.72) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. IBLLX (41.00). RLBCX has a lower initial minimum investment than IBLLX: RLBCX (250) vs IBLLX (1000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. IBLLX (2.61). RLBCX return over 5 years is better than : 40.24 vs. IBLLX (19.75).
IBLLXRLBCXIBLLX / RLBCX
Total Expense Ratio1.720.89193%
Annual Report Gross Expense Ratio1.720.89193%
Fund Existence23 years23 years-
Gain YTD10.11714.36470%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.5B265B1%
Annual Yield % from dividends0.731.4949%
Returns for 1 year2.618.3431%
Returns for 3 years35.6049.2672%
Returns for 5 years19.7540.2449%
Returns for 10 years54.3972.1875%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYOCY13.390.18
+1.39%
Kyocera Corp.
ZLDAF0.21N/A
N/A
Zelira Therapeutics Ltd.
FRTAY16.68N/A
N/A
Freenet AG
ALPIB33.59-0.01
-0.03%
Alpine Banks of Colorado
PBKX10.81-0.04
-0.37%
Partners Bank California